All Type of News
LG Life Sciences sign a deal to introduce Demomed's Gastric Retention
LG Life Sciences said that it signed an exclusive license agreement with the US-based Depomed Inc. to distribute Metformin Gastric Retention (GR) in Korea.
Depomed filed an US NDA for Metformin GR for use in the t...
Pfizer Korea holds seminar on Mens' Health Forum
The first Mens' Health Forum was held on August 21 in Chunbuk Province for 110 Korean urologists.
Its organizer, Pfizer Korea, said that the seminar was designed to establish new emerging therapeutic strategies for...
Functional health foods shall not be prescribed.
Despite the MOHW's interpretation that the physician's prescription of functional health food supplements be legally unjustifiable, many western and oriental doctors are still prescribing them continuously probably be...
Samjin studying anti-cancer drug development, SJ-8002.
Samjin announced that SJ-8002, an anti-cancer drug of piperazine derivative, was successfully developed having an anti-cancer mode of actions by blocking the microtubule generation, angiogenesis and inducement of tumo...
New product licenses totals 684 in first half
The Korea Food and Drug Administration announced that licenses for new products in the first half of this year totaled 684, thanks to surging trend in the number of newly-tested bioequivalence items. Of the ...
Proprietors of pharmacy urged to promote OTC sales
Pharmaceutical business sources say that proprietors of pharmacy should brace for improving their management conditions via a variety of business diversification programs including activated OTC sales to help conserve...
Pharmacy NHI reimbursement at less than 3 million won per month.
About 2,000 pharmacies were found to bill the NHI reimbursement at less than 3 million won in contrast with 11 pharmacies at more than 600 million won, about 1,850 prescription filling per day on average.
The Yaku...
5 weekday work system to batter prescription relied pharmacies.
As a result of implementing the 5 weekday work system at most of general hospitals, the first line of victims appeared to the pharmacies located near such hospitals where most of their business largely relied on the h...
NovoMix 30 Flexpen to be available in KoreaNovo Nordisk Korea announced on August 19 that NovoMix 30 Flexpen (reimbursable price: 11,706 won/3ml), the dual-release insulin analogue and pen system designed specifically fo...
|
Domestic pharmaceutical firms' R&D overseas projects seen intensifying
A number of domestic leading pharmaceutical firms are expected to increase their R&D investment in foreign countries, as the Korea Pharmaceutical Manufacturers Association and the Korea Health Industry Development Ins...
